Alembic Pharma acquires 100% stake in Aleor Dermaceuticals
Summary : The company has acquired remaining 40 per cent stake from Orbicular Pharmaceutical Technologies, to have 100 per cent holding in…
Summary : The company has acquired remaining 40 per cent stake from Orbicular Pharmaceutical Technologies, to have 100 per cent holding in…
Summary : Alembic Pharmaceuticals received a tentative approval from the United States Food & Drug Administration (USFDA) for its Abbreviated New Drug…
Summary : Alembic said it has so far received 15 product approvals this year. Alembic Pharma received approval from the US health…